Skin Problems in Alzheimer Disease, Dementia and Other Cerebrovascular Problems
Özet
Dementia and Alzheimer's disease are neurological disorders characterized by progressive cognitive dysfunction. Numerous studies have shown a link between Alzheimer's disease and certain skin conditions. The relationship between Alzheimer's disease and autoimmune bullous diseases has been the most frequently studied, and the risk of developing bullous pemphigoid has been shown to be higher in Alzheimer's patients. Another study found that non-melanoma skin cancer is associated with a reduced risk of Alzheimer's disease. Similar associations have been shown between skin conditions such as hidradenitis suppurativa, psoriasis, skin cancers, and cutaneous amyloidosis and dementia, Alzheimer's disease, and other cerebrovascular events.
Referanslar
Zhang, H., Zhang, D., Tang, K., & Sun, Q. (2021). The Relationship Between Alzheimer's Disease and Skin Diseases: A Review. Clinical, cosmetic and investigational dermatology, 14, 1551–1560. https://doi.org/10.2147/CCID.S322530
Clos AL, Kayed R, Lasagna-Reeves CA. Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis. Front Neurol. 2012;3:5. doi:10.3389/fneur.2012.000055.
Akerman SC, Hossain S, Shobo A, et al. Neurodegenerative disease-related proteins within the epidermal layer of the human skin. J Alzheimers Dis. 2019;69(2):463–478. doi:10.3233/JAD- 181191
Kim HS, Jung H, Park YH, Heo SH, Kim S, Moon M. Skin-brain axis in Alzheimer's disease - Pathologic, diagnostic, and therapeutic implications: A Hypothetical Review. Aging Dis. Published online April 19, 2024. doi:10.14336/AD.2024.0406
Försti AK, Jokelainen J, Ansakorpi H, et al. Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study. Sci Rep. 2016;6:37125. doi:10.1038/srep371257.
White RS, Lipton RB, Hall CB, Steinerman JR. Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk. Neurology. 2013;80(21):1966–1972. doi:10.1212/WNL.0b013e31829419908.
Hammers CM, Stanley JR. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Annu Rev Pathol. 2016;11:175-197. doi:10.1146/annurev-pathol-012615-044313
Xie Z, Gao Y, Tian L, Jiang Y, Zhang H, Su Y. Pemphigus and pemphigoid are associated with Alzheimer's disease in older adults: evidence from the US Nationwide inpatient sample 2016-2018. BMC Geriatr. 2023;23(1):872. Published 2023 Dec 19. doi:10.1186/s12877-023-04580-z
Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol. 2011;131(3):631–636. doi:10.1038/jid.2010.35715.
Lai YC, Yew YW, Lambert WC. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2016;30 (12):2007–2015. doi:10.1111/jdv.1366016.
Taghipour K, Chi CC, Vincent A, Groves RW, Venning V, Wojnarowska F. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol. 2010;146(11):1251–1254. doi:10.1001/archder matol.2010.32217.
Messingham KN, Miller AD, Narayanan NS, Connell SJ, Fairley JA. Demographics and autoantibody profiles of pemphigoid patients with underlying neurologic diseases. J Invest Dermatol. 2019;139(9):1860–1866. doi:10.1016/j.jid.2019.01.03418.
Kibsgaard L, Rasmussen M, Lamberg A, Deleuran M, Olesen AB, Vestergaard C. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid. Br J Dermatol. 2017;176 (6):1486–1491. doi:10.1111/bjd.1540522.
Zhao W, Wang Y, Mao X, et al. Detection of underlying dementia in bullous pemphigoid patients using cognitive evaluation tests: a multicenter case-control study. Ann Transl Med. 2020;8 (21):1397. doi:10.21037/atm-20-1319
Papakonstantinou E, Limberg MM, Gehring M, et al. Neurological disorders are associated with bullous pemphigoid. J Eur Acad Dermatol Venereol. 2019;33(5):925–929. doi:10.1111/ jdv.1544423.
Seppänen A, Suuronen T, Hofmann SC, Majamaa K, Alafuzoff I. Distribution of collagen XVII in the human brain. Brain Res. 2007;1158:50–56. doi:10.1016/j.brainres.2007.04.07324.
Kridin K, Hübner F, Recke A, Linder R, Schmidt E. The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study. J Eur Acad Dermatol Venereol. 2021. doi:10.1111/jdv.1746526.
Seppänen A. Collagen XVII: a shared antigen in neurodermatological interactions? Clin Dev Immunol. 2013;2013:240570. doi:10.1155/2013/24057027.
Chen J, Li L, Chen J, et al. Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain. Gerontology. 2011;57 (3):211–216. doi:10.1159/00031539328.
Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association Between Pemphigus and Neurologic Diseases. JAMA Dermatol. 2018;154(3):281-285. doi:10.1001/jamadermatol.2017.5799
Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18. Published 2020 Mar 12. doi:10.1038/s41572-020-0149-1
De Strooper B, Iwatsubo T, Wolfe MS. Presenilins and γ- secretase: structure, function, and role in Alzheimer Disease. Cold Spring Harb Perspect Med. 2012;2(1):a006304. doi:10.1101/cshperspect.a00630442.
Garg A, Strunk A. Risk of Alzheimer’s disease is not increased among patients with hidradenitis suppurativa: a retrospective population-based cohort analysis. J Am Acad Dermatol. 2017;77 (1):176–177. doi:10.1016/j.jaad.2017.02.05554.
Theut Riis P, Egeberg A, Gislason GH, Jemec GB. Patients with hidradenitis suppurativa have no increased risk of Alzheimer disease. Br J Dermatol. 2017;177(1):273–275. doi:10.1111/ bjd.1506455.
Esme P, Esme M, Caliskan E. Increased prevalence of family history of Alzheimer’s disease in hidradenitis suppurativa: cross- sectional analysis of 192 HS patients. Dermatol Ther. 2020;33(6): e14219. doi:10.1111/dth.1421959.
Leisner MZ, Riis JL, Schwartz S, Iversen L, Østergaard SD, Olsen MS. Psoriasis and risk of mental disorders in Denmark. JAMA Dermatol. 2019;155(6):745–747. doi:10.1001/jamad ermatol.2019.003966.
Kim M, Park HE, Lee SH, Han K, Lee JH. Increased risk of Alzheimer’s disease in patients with psoriasis: a nationwide population-based cohort study. Sci Rep. 2020;10(1):6454. doi:10.1038/ s41598-020-63550-267.
Huang KL, Yeh CC, Wu SI, et al. Risk of dementia among individuals with psoriasis: a nationwide population-based cohort study in Taiwan. J Clin Psychiatry. 2019;80(3):18m12462. doi:10.4088/JCP.18m1246268.
Lin CC, Lin HC, Chiu HW. Association between psoriasis and dementia: a population-based case-control study. Am J Clin Dermatol. 2019;20(3):457–463. doi:10.1007/s40257-018-00420-869.
Pezzolo E, Mutlu U, Vernooij MW, et al. Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study. J Am Acad Dermatol. 2018. doi:10.1016/j.jaad.2018.07.04670.
Liu L, Chen ST, Li HJ, et al. Association between psoriasis and dementia: current evidence. Front Aging Neurosci. 2020;12:570992. doi:10.3389/fnagi.2020.57099271.
Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586–592. doi:10.1111/j.1365-2133.2010.09941.x72.
Gisondi P, Sala F, Alessandrini F, et al. Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology. 2014;228(1):78–85. doi:10.1159/00035722073.
Colgecen E, Celikbilek A, Keskin DT. Cognitive impairment in patients with psoriasis: a cross-sectional study using the Montreal cognitive assessment. Am J Clin Dermatol. 2016;17(4):413–419. doi:10.1007/s40257-016-0187-374.
Decourt B, Lahiri DK, Sabbagh MN. Targeting tumor necrosis factor alpha for Alzheimer’s disease. Curr Alzheimer Res. 2017;14(4):412–425. doi:10.2174/156720501366616093011055175.
Ospina-Romero M, Glymour MM, Hayes-Larson E, et al. Association between Alzheimer disease and cancer with evaluation of study biases: a systematic review and meta-analysis. JAMA Network Open. 2020;3(11):e2025515. doi:10.1001/ jamanetworkopen.2020.2551587.
Schmidt SA, Ording AG, Horváth-Puhó E, Sørensen HT, Henderson VW. Non-melanoma skin cancer and risk of Alzheimer’s disease and all-cause dementia. PLoS One. 2017;12 (2):e0171527. doi:10.1371/journal.pone.017152790.
Ibler E, Tran G, Orrell KA, et al. Inverse association for diagnosis of Alzheimer’s disease subsequent to both melanoma and non- melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population. J Eur Acad Dermatol Venereol. 2018;32(11):1893–1896. doi:10.1111/jdv.1495291.
Awal G, Kaur S. Association of cutaneous amyloidosis with neurodegenerative amyloidosis: correlation or coincidence? J Clin Aesthet Dermatol. 2018;11(4):25–27.108.
Al Aboud D, Broshtilova V, Al Aboud K, Al Hawsawi K. Dermatological aspects of cerebrovascular diseases. Acta Dermatovenerol Alp Pannonica Adriat. 2005;14(1):9-14.
